<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01429389</url>
  </required_header>
  <id_info>
    <org_study_id>SQNM-T21-107</org_study_id>
    <nct_id>NCT01429389</nct_id>
  </id_info>
  <brief_title>Specimen Collection From Pregnant Women at Increased Risk for Fetal Aneuploidy</brief_title>
  <official_title>Collection of Whole Blood Specimens From Pregnant Women at Increased Risk of Fetal Chromosomal Abnormality for Use in Development of a Noninvasive Prenatal Test in the Detection of the Relative Quantity of Chromosomal Material in Circulating Cell-Free DNA Extracted From Maternal Plasma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sequenom, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sequenom, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The specimen collection is designed for the purpose of the development of a noninvasive
      prenatal test for T21.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To collect specimens for the purpose of developing a prenatal aneuploidy test. The test will
      analyze circulating cell free fetal (ccff) nucleic acid from blood samples from pregnant
      women who have an increased risk indicator/s for fetal chromosomal aneuploidy and are
      undergoing invasive prenatal diagnosis by chorionic villus sampling (CVS) and/or genetic
      amniocentesis. The results of the ccff aneuploidy test will be compared to the chromosomal
      analysis obtained via CVS or genetic amniocentesis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Down Syndrome</condition>
  <condition>Fetal Aneuploidy</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood specimens will be collected and processed to plasma. DNA will be extracted from
      the plasma.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant women between 10 and 22 weeks of gestation who are scheduled to undergo a CVS or
        amniocentesis procedure and will receive the fetal FISH, karyotype and/or QF-PCR results
        from the procedure.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  pregnant between 10 and 22 weeks gestation

          -  18 years of age or older

          -  provides signed and dated informed consent

          -  subject is at increased risk for fetal aneuploidy

          -  subject is willing to undergo a CVS and/or amniocentesis procedure for the purpose of
             genetic analysis

          -  subject agrees to provide the genetic results of the invasive procedure

        Exclusion Criteria:

          -  Fetal demise at time of specimen sampling

          -  Previous sample donation under this protocol
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Grosu, MD</last_name>
    <role>Study Director</role>
    <affiliation>Sequenom, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Copper</last_name>
      <phone>205-934-5509</phone>
      <email>rachel.copper@obgyn.uab.edu</email>
    </contact>
    <investigator>
      <last_name>Joseph Biggio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deebra Smith, MD</last_name>
      <phone>310-423-5860</phone>
    </contact>
    <investigator>
      <last_name>John Williams, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sharp-Rees Stealy Medical Group</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary LaPage</last_name>
      <phone>619-446-1624</phone>
    </contact>
    <investigator>
      <last_name>Denis Tarakjian, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UCSD</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jason Chibuck</last_name>
      <email>jchibuck@ucsd.edu</email>
    </contact>
    <investigator>
      <last_name>Andrew Hull, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Women's Health Care Research</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nora Martinez</last_name>
      <phone>858-505-8672</phone>
      <email>research@womenwellness.com</email>
    </contact>
    <investigator>
      <last_name>Rovena Reagan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Specialty Obstetrics of San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92130</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Deborah Malone</last_name>
      <phone>858-794-7700</phone>
      <email>d.malone@specialtyobstetrics.com</email>
    </contact>
    <investigator>
      <last_name>David Dowling, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Reproductive Genetics Institute</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60602</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Denise Ginsberg</last_name>
      <phone>773-472-4900</phone>
    </contact>
    <investigator>
      <last_name>Norman Ginsberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Iowa Health Care</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diedre Fleener</last_name>
      <phone>319-356-2913</phone>
      <email>deidre-fleener@uiowa.edu</email>
    </contact>
    <investigator>
      <last_name>Kristi Borowski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ellen Martindell</last_name>
      <phone>313-916-3190</phone>
      <email>emartin1@hfhs.org</email>
    </contact>
    <investigator>
      <last_name>Jacquelyn Roberson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spectrum Health</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yvonne Edgerly</last_name>
      <phone>616-391-5066</phone>
    </contact>
    <investigator>
      <last_name>Asad Sheikh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Cooper Health System</name>
      <address>
        <city>Camden</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clare Hanson</last_name>
      <email>hansen-clare@cooperhealth.edu</email>
    </contact>
    <investigator>
      <last_name>Meena Khandelwal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29466</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Betty Oswald</last_name>
      <phone>843-792-0347</phone>
      <email>oswaldbw@musc.edu</email>
    </contact>
    <investigator>
      <last_name>Christopher Robinson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IWK Health Centre</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3K 6R8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cora Fanning</last_name>
      <phone>902 470-7158</phone>
      <email>cora.fanning@iwk.nshealth.ca</email>
    </contact>
    <investigator>
      <last_name>Jo-Ann Brock, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>North York General Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clare Gibbons</last_name>
      <phone>416 756-6788</phone>
      <email>clare.gibbons@nygh.on.ca</email>
    </contact>
    <investigator>
      <last_name>Wendy Meschino, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 2, 2011</study_first_submitted>
  <study_first_submitted_qc>September 6, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 7, 2011</study_first_posted>
  <last_update_submitted>October 27, 2016</last_update_submitted>
  <last_update_submitted_qc>October 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 31, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Down syndrome</keyword>
  <keyword>fetal aneuploidy</keyword>
  <keyword>trisomy</keyword>
  <keyword>noninvasive screening test</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Down Syndrome</mesh_term>
    <mesh_term>Aneuploidy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Samples are used for research and development of a noninvasive prenatal test. However, samples used for publications will have data shared as defined by journal.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

